微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 76.36% | -8.13% | -2.44% | 10/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 78.28% | -2.31% | -0.05% | 8/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 78.32% | -3.26% | -2.6% | 8/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 80.4% | -1.48% | -3.27% | 5/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 83.12% | -0.51% | 3.74% | 3/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 80.12% | 5.45% | -1.02% | 5/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 80.95% | 13.06% | -0.81% | 5/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 81.61% | 15.11% | -2.32% | 4/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 83.55% | 27% | 9.96% | 4/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 75.98% | 24.15% | 6.12% | 13/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 71.6% | 12.73% | 0.99% | 21/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 70.9% | 9.91% | 7.77% | 27/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 65.79% | 0.41% | 7.49% | 41/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 61.2% | -20.17% | -3.65% | 51/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 63.52% | 2% | -1.53% | 46/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 64.51% | -18.01% | -1.54% | 46/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 65.52% | 2% | -14.54% | 41/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 76.67% | -14.19% | -2.55% | 17/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-06-30 | 78.67% | 2% | -11.95% | 16/140 | 59.05% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 89.35% | 2% | 2% | 3/140 | 60.12% | 三友医疗 | 90.29% | 行业排名> |